We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pre-market indices are gamely climbing again this morning, after starting early-morning trading in the red. Currently, the Dow is +45 points, the S&P 500 +5, the market-leading Nasdaq +6 and even the small-cap Russell 2000 is in the green, +0.4 points. The Dow rides its longest winning streak since July of this year, while the S&P and Nasdaq are enjoying their strongest moves since 2021.
We’re a bit light on economic prints this morning and throughout this Hump Day, although we did see Wholesale Inventories for September out this morning, coming in an expected 0.0% on the headline, which is an improvement after six straight months of negative wholesale inventories. It’s only the third non-negative read in the past 10 months, and we haven’t seen a positive result on this metric since November of last week. Higher inventories will help put downward pressure on inflation.
Ahead of today’s open, Ralph Lauren (RL - Free Report) posted fiscal Q2 results that were ahead of estimates on both top and bottom lines. Earnings of $2.10 per share easily toppled the $1.92 forecast in the Zacks consensus (though still below the $2.23 per share reported in the year-ago quarter. Quarterly sales of $1.63 billion came in ahead of the $1.61 billion projected, as the company boasted +1.3 million growth in new direct-to-consumer (DTC) subscribers in the quarter. Full-year guidance was held pat. Shares are up +2% on the news.
Warner Bros. Discovery (WBD - Free Report) , however, missed its bottom-line estimate, putting up -17 cents per share which was 5 cents lower than the Zacks consensus. Revenues did post higher than predicted, with $9.97 billion in the quarter coming ahead of the $9.89 billion anticipated. Even with the “Barbie boost” — its blockbuster film grossed $1.5 billion since its release — the company has struggled with the loss of -700K subscribers in the quarter. Shares are down -12% in early trading.
Biotech giant Biogen (BIIB - Free Report) notched a strong Q3 this morning, putting up $4.36 per share versus $3.99 expected on revenues of $2.53 billion, ahead of the $2.39 billion projected. While the company continues to win FDA approval for treatments of ALS and Alzheimer’s disease, the lion’s share — $1.16 billion of its total $1.805 billion product revenue — comes from its Multiple Sclerosis (MS) line. Shares are up marginally ahead of the opening bell, but are still down single-digits year to date.
After the close today, we’ll see earnings results from The Walt Disney Co. (DIS - Free Report) , Arm Holdings (ARM - Free Report) and MGM Resorts (MGM - Free Report) , among many others. It should be interesting to see Disney’s results in particular, if only to be able to compare streaming services: Disney+ versus HBO MAX, Discovery+, etc. We’ll also hear from Fed participants today, including Fed Chair Jerome Powell later this morning. Questions or comments about this article and/or author? Click here>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Pre-Markets Keep Streak Alive; RL, BIIB Beat
Pre-market indices are gamely climbing again this morning, after starting early-morning trading in the red. Currently, the Dow is +45 points, the S&P 500 +5, the market-leading Nasdaq +6 and even the small-cap Russell 2000 is in the green, +0.4 points. The Dow rides its longest winning streak since July of this year, while the S&P and Nasdaq are enjoying their strongest moves since 2021.
We’re a bit light on economic prints this morning and throughout this Hump Day, although we did see Wholesale Inventories for September out this morning, coming in an expected 0.0% on the headline, which is an improvement after six straight months of negative wholesale inventories. It’s only the third non-negative read in the past 10 months, and we haven’t seen a positive result on this metric since November of last week. Higher inventories will help put downward pressure on inflation.
Ahead of today’s open, Ralph Lauren (RL - Free Report) posted fiscal Q2 results that were ahead of estimates on both top and bottom lines. Earnings of $2.10 per share easily toppled the $1.92 forecast in the Zacks consensus (though still below the $2.23 per share reported in the year-ago quarter. Quarterly sales of $1.63 billion came in ahead of the $1.61 billion projected, as the company boasted +1.3 million growth in new direct-to-consumer (DTC) subscribers in the quarter. Full-year guidance was held pat. Shares are up +2% on the news.
Warner Bros. Discovery (WBD - Free Report) , however, missed its bottom-line estimate, putting up -17 cents per share which was 5 cents lower than the Zacks consensus. Revenues did post higher than predicted, with $9.97 billion in the quarter coming ahead of the $9.89 billion anticipated. Even with the “Barbie boost” — its blockbuster film grossed $1.5 billion since its release — the company has struggled with the loss of -700K subscribers in the quarter. Shares are down -12% in early trading.
Biotech giant Biogen (BIIB - Free Report) notched a strong Q3 this morning, putting up $4.36 per share versus $3.99 expected on revenues of $2.53 billion, ahead of the $2.39 billion projected. While the company continues to win FDA approval for treatments of ALS and Alzheimer’s disease, the lion’s share — $1.16 billion of its total $1.805 billion product revenue — comes from its Multiple Sclerosis (MS) line. Shares are up marginally ahead of the opening bell, but are still down single-digits year to date.
After the close today, we’ll see earnings results from The Walt Disney Co. (DIS - Free Report) , Arm Holdings (ARM - Free Report) and MGM Resorts (MGM - Free Report) , among many others. It should be interesting to see Disney’s results in particular, if only to be able to compare streaming services: Disney+ versus HBO MAX, Discovery+, etc. We’ll also hear from Fed participants today, including Fed Chair Jerome Powell later this morning.
Questions or comments about this article and/or author? Click here>>